ASCO Virtual Meeting, 29 May–2 June 2020

An open-label, Phase I trial of BI 754091 alone and in combination with BI 754111 in Asian patients with advanced solid tumors

 

Yoon-Koo Kang, Kensei Yamaguchi, Do-Youn Oh, Shunsuke Kondo, Yasutoshi Kuboki, Manabu Morimoto, Hiroki Hara, Sun Young Rha, Chia-Chi Lin, Yoshifumi Tachibana, Miaomiao Ge, Mabrouk Elgadi, Shigehisa Kitano

asco_2020_poster_118_kang_lag3_pd1_1381.4.png

  • Introduction

introduction.png

  • Methods

Methods

Methods (cont'd)

Methods (cont'd)

  • Results – Patient demographics (Part 3)

Results – Patient demographics (Part 3)

  • References

References

Related Materials

Learn more about the science behind this poster in the videos, papers and other materials below.

FOR HEALTHCARE PROFESSIONAL ONLY

links_to_3rd_party.jpg